Literature DB >> 29700559

[Primary sclerosing cholangitis : Current diagnostics and treatment].

T Liwinski1, C Schramm2,3.   

Abstract

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology. Characteristic features are multifocal strictures and dilatations of the bile ducts. In 60-80 % of cases the PSC is strongly associated with chronic inflammatory bowel disease, mostly in the form of pancolitis. The diagnosis is established based on detection of typical cholangiographic lesions of the bile ducts and exclusion of secondary causes of sclerosing cholangitis. There is no approved medical treatment, but in Germany ursodeoxycholic acid is frequently used. Clinically relevant stenoses can be successfully treated by interventional endoscopy. Patients with PSC suffer from a greatly increased risk of hepatobiliary malignancies, especially with respect to cholangiocarcinoma and colorectal cancer and therefore require regular surveillance and screening. Liver transplantation is currently the only curative treatment option.

Entities:  

Keywords:  Cholangiocarcinoma; Cholangiopancreatography, endoscopic retrograde; Inflammatory bowel diseases; Liver transplantation; Ursodeoxycholic acid

Mesh:

Year:  2018        PMID: 29700559     DOI: 10.1007/s00108-018-0428-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  31 in total

Review 1.  Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group.

Authors:  Christoph Schramm; John Eaton; Kristina I Ringe; Sudhakar Venkatesh; Jin Yamamura
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

2.  Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Authors:  K M Boberg; A Bergquist; S Mitchell; A Pares; F Rosina; U Broomé; R Chapman; O Fausa; T Egeland; G Rocca; E Schrumpf
Journal:  Scand J Gastroenterol       Date:  2002-10       Impact factor: 2.423

3.  Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis.

Authors:  M Kaya; B T Petersen; P Angulo; T H Baron; J C Andrews; C J Gostout; K D Lindor
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

4.  ACG Clinical Guideline: Primary Sclerosing Cholangitis.

Authors:  Keith D Lindor; Kris V Kowdley; M Edwyn Harrison
Journal:  Am J Gastroenterol       Date:  2015-04-14       Impact factor: 10.864

5.  Bone disease in patients with primary sclerosing cholangitis.

Authors:  Paul Angulo; Garfield A Grandison; Derek G Fong; Jill C Keach; Keith D Lindor; Einar Bjornsson; Alvaro Koch
Journal:  Gastroenterology       Date:  2010-10-16       Impact factor: 22.682

Review 6.  Bile acids for primary sclerosing cholangitis.

Authors:  Goran Poropat; Vanja Giljaca; Davor Stimac; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

7.  Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.

Authors:  Kirsten Boonstra; Rinse K Weersma; Karel J van Erpecum; Erik A Rauws; B W Marcel Spanier; Alexander C Poen; Karin M van Nieuwkerk; Joost P Drenth; Ben J Witteman; Hans A Tuynman; Anton H Naber; Paul J Kingma; Henk R van Buuren; Bart van Hoek; Frank P Vleggaar; Nan van Geloven; Ulrich Beuers; Cyriel Y Ponsioen
Journal:  Hepatology       Date:  2013-10-17       Impact factor: 17.425

8.  A population-based cohort study of pregnancy outcomes among women with primary sclerosing cholangitis.

Authors:  Jonas F Ludvigsson; Annika Bergquist; Gunilla Ajne; Sunanda Kane; Anders Ekbom; Olof Stephansson
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-23       Impact factor: 11.382

Review 9.  Primary sclerosing cholangitis.

Authors:  Gideon M Hirschfield; Tom H Karlsen; Keith D Lindor; David H Adams
Journal:  Lancet       Date:  2013-06-28       Impact factor: 79.321

10.  Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis.

Authors:  Ahmad Hassan Ali; James H Tabibian; Navine Nasser-Ghodsi; Ryan J Lennon; Thomas DeLeon; Mitesh J Borad; Moira Hilscher; Marina G Silveira; Elizabeth J Carey; Keith D Lindor
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

View more
  1 in total

Review 1.  Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Authors:  Fotios S Fousekis; Vasileios I Theopistos; Ioannis V Mitselos; Alexandros Skamnelos; Athanasios Kavvadias; Konstantinos H Katsanos; Dimitrios K Christodoulou
Journal:  J Clin Med Res       Date:  2019-01-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.